|
US5846983A
(en)
*
|
1996-02-09 |
1998-12-08 |
Mayo Foundation For Medical Education And Research |
Colonic delivery of nicotine to treat inflammatory bowel disease
|
|
US20020039596A1
(en)
*
|
1997-11-14 |
2002-04-04 |
Hartoun Hartounian |
Production of multivesicular liposomes
|
|
EP1900283A3
(en)
|
1998-03-23 |
2010-02-10 |
General Mills, Inc. |
Encapsulation of components into edible products
|
|
AUPP627498A0
(en)
|
1998-10-02 |
1998-10-22 |
University Of Queensland, The |
Novel peptides - i
|
|
DE19847715A1
(de)
*
|
1998-10-16 |
2000-04-20 |
Lohmann Therapie Syst Lts |
Verfahren zur Behandlung der Schizophrenie sowie Mittel zur Verwendung in diesem Verfahren
|
|
EP1225897B1
(en)
*
|
1999-11-01 |
2004-09-08 |
RHODES, John |
Composition for treatment of constipation and irritable bowel syndrome
|
|
US6468568B1
(en)
|
2000-06-16 |
2002-10-22 |
General Mills, Inc. |
Oligosaccharide encapsulated mineral and vitamin ingredients
|
|
US6436453B1
(en)
|
2000-06-16 |
2002-08-20 |
General Mills, Inc. |
Production of oil encapsulated minerals and vitamins in a glassy matrix
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
DE60143360D1
(de)
*
|
2000-08-03 |
2010-12-09 |
Antares Pharma Ipl Ag |
Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert
|
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
|
CA2341952A1
(en)
|
2001-03-23 |
2002-09-23 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
|
|
US7081475B2
(en)
|
2001-09-14 |
2006-07-25 |
Prolx Pharmaceuticals Corp. |
Wortmannin analogs and methods of using same
|
|
US20040037879A1
(en)
*
|
2001-11-02 |
2004-02-26 |
Adusumilli Prasad S. |
Oral controlled release forms useful for reducing or preventing nicotine cravings
|
|
US8557804B2
(en)
|
2002-03-25 |
2013-10-15 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
|
US8039459B2
(en)
|
2004-07-15 |
2011-10-18 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
|
NZ540518A
(en)
|
2002-12-02 |
2006-12-22 |
Xenome Ltd |
Novel x-conotoxin peptides (-I)
|
|
EP2386566A3
(en)
|
2002-12-02 |
2012-02-15 |
Xenome Ltd |
Chi-conotoxin peptides (II)
|
|
US8337891B2
(en)
|
2003-07-03 |
2012-12-25 |
Sucampo Ag |
Enteric coated composition comprising prostaglandin analogs as chloride channel opener
|
|
HUE037508T2
(hu)
|
2003-07-24 |
2018-09-28 |
Glaxosmithkline Llc |
Szájban oldódó filmek
|
|
EP1661574B1
(en)
*
|
2003-09-01 |
2017-04-19 |
Earthus, Inc. |
Beta-hydroxy short to medium chain fatty acid polymer
|
|
MXPA06003316A
(es)
|
2003-10-10 |
2006-06-08 |
Antares Pharma Ipl Ag |
Formulacion farmaceutica transdermica para minimizar los residuos en la piel.
|
|
CA2571554A1
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
|
|
EP1802258A4
(en)
|
2004-09-13 |
2015-09-23 |
Chrono Therapeutics Inc |
BIOSYNCHRONE TRANSDERMAL MEDICINES
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
WO2007124250A2
(en)
*
|
2006-04-21 |
2007-11-01 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
|
US8067399B2
(en)
*
|
2005-05-27 |
2011-11-29 |
Antares Pharma Ipl Ag |
Method and apparatus for transdermal or transmucosal application of testosterone
|
|
US20070078376A1
(en)
*
|
2005-09-30 |
2007-04-05 |
Smith Gregory A |
Functionalized microneedles transdermal drug delivery systems, devices, and methods
|
|
KR20080066712A
(ko)
*
|
2005-09-30 |
2008-07-16 |
티티아이 엘뷰 가부시키가이샤 |
관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
|
|
KR20080080087A
(ko)
*
|
2005-09-30 |
2008-09-02 |
티티아이 엘뷰 가부시키가이샤 |
신규 약학 담체를 이용한 경피 약물 전달시스템, 장치 및방법
|
|
US7803413B2
(en)
|
2005-10-31 |
2010-09-28 |
General Mills Ip Holdings Ii, Llc. |
Encapsulation of readily oxidizable components
|
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
|
JP5504534B2
(ja)
|
2007-03-30 |
2014-05-28 |
有限会社アーザス |
ケトン体生成促進剤組成物
|
|
ES2521494T3
(es)
*
|
2007-04-02 |
2014-11-12 |
Parkinson's Institute |
Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
|
|
KR20100020008A
(ko)
*
|
2007-05-18 |
2010-02-19 |
티티아이 엘뷰 가부시키가이샤 |
생물학적 인터페이스를 통한 활성 성분의 방출을 개선한 경피 전달 장치
|
|
TW200948383A
(en)
*
|
2008-05-19 |
2009-12-01 |
Univ Nat Taiwan |
System for determining function of intestinal barrier
|
|
US20110268809A1
(en)
|
2010-04-28 |
2011-11-03 |
Paul Andrew Brinkley |
Nicotine-Containing Pharmaceutical Compositions
|
|
US20110274628A1
(en)
|
2010-05-07 |
2011-11-10 |
Borschke August J |
Nicotine-containing pharmaceutical compositions
|
|
DK2654738T3
(en)
*
|
2010-12-21 |
2018-07-23 |
Fertin Pharma As |
CHEESE GUM COMPOSITION COMPREHENSIVE CROSS-POLYACRYLIC ACID
|
|
WO2013006643A1
(en)
*
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
|
US20130078307A1
(en)
|
2011-09-22 |
2013-03-28 |
Niconovum Usa, Inc. |
Nicotine-containing pharmaceutical composition
|
|
US9907748B2
(en)
|
2011-10-21 |
2018-03-06 |
Niconovum Usa, Inc. |
Excipients for nicotine-containing therapeutic compositions
|
|
US9763928B2
(en)
|
2012-02-10 |
2017-09-19 |
Niconovum Usa, Inc. |
Multi-layer nicotine-containing pharmaceutical composition
|
|
LT2861229T
(lt)
*
|
2012-06-15 |
2021-01-25 |
Conaris Research Institute Ag |
Farmacinė kompozicija, apimanti nikotino rūgštį ir (arba) nikotinamidą ir (arba) triptofaną, skirta teigiamai paveikti žarnyno mikrobiotai
|
|
AU2012386221A1
(en)
|
2012-07-26 |
2015-02-26 |
Wockhardt Limited |
Pharmaceutical composition comprising diamorphine for intranasal administration
|
|
US20140255452A1
(en)
|
2013-03-11 |
2014-09-11 |
Niconovum Usa, Inc. |
Method and apparatus for differentiating oral pouch products
|
|
EP3079704B1
(en)
|
2013-12-13 |
2019-01-02 |
CONARIS research institute AG |
A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
|
|
ES2788866T3
(es)
|
2013-12-13 |
2020-10-23 |
Conaris Res Institute Ag |
Una composición farmacéutica que contiene ácido nicotínico y/o nicotinamida para su uso en influir beneficiosamente en los niveles de lípidos en sangre mediante la modificación de la microbiota intestinal
|
|
EP3154530B1
(en)
|
2014-06-10 |
2018-04-04 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Nanoparticulate complex of nicotine and cerium oxide and use thereof
|
|
JP2018511355A
(ja)
|
2015-01-28 |
2018-04-26 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
薬剤送達方法及びシステム
|
|
JP2018511127A
(ja)
|
2015-03-12 |
2018-04-19 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
渇望入力及び支援システム
|
|
CA2997915A1
(en)
*
|
2015-09-15 |
2017-03-23 |
C.B. Fleet Company, Incorporated |
Bisacodyl compositions and delivery apparatus
|
|
US10532046B2
(en)
|
2015-12-03 |
2020-01-14 |
Niconovum Usa, Inc. |
Multi-phase delivery compositions and products incorporating such compositions
|
|
US20170165252A1
(en)
|
2015-12-10 |
2017-06-15 |
Niconovum Usa Inc. |
Protein-enriched therapeutic composition
|
|
US10143687B2
(en)
|
2016-04-11 |
2018-12-04 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
|
US10292977B2
(en)
|
2016-04-11 |
2019-05-21 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
|
WO2018113916A1
(en)
*
|
2016-12-20 |
2018-06-28 |
Fertin Pharma A/S |
A mucoadhesive oromucosal formulation comprising a nicotine complex
|
|
JP2020503950A
(ja)
|
2017-01-06 |
2020-02-06 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
経皮薬剤送達の装置及び方法
|
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
EP3807260B1
(en)
|
2018-06-15 |
2024-09-18 |
R. J. Reynolds Tobacco Company |
Purification of nicotine
|
|
CA3119992A1
(en)
|
2018-11-16 |
2020-05-22 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|